Epigenetic age acceleration and methylation differences in IgG4-related cholangitis and primary sclerosing cholangitis.
Noble A. et al, (2025), Clinical epigenetics, 17
Evaluation of intestinal biopsy tissue preservation methods to facilitate large-scale mucosal microbiota research.
Wyatt NJ. et al, (2024), EBioMedicine, 112
Exposure to air pollution increases susceptibility to ulcerative colitis through epigenetic alterations in CXCR2 and MHC class III region.
Chen J. et al, (2024), EBioMedicine, 110
The circulating methylome in childhood-onset inflammatory bowel disease.
Noble A. et al, (2024), Journal of Crohn's & colitis
Prenatal cannabis exposure is associated with alterations in offspring DNA methylation at genes involved in neurodevelopment, across the life course.
Noble AJ. et al, (2024), Molecular psychiatry
Intestinal Inflammation and Extraintestinal Disease: Understanding Dynamic Risk.
Ashton JJ. et al, (2024), Gastroenterology, 167, 205 - 208
Treatment strategies and biomarkers in Crohn's disease: the PROFILE trial.
Satsangi J. et al, (2024), The lancet. Gastroenterology & hepatology, 9, 591 - 592
Biologic Therapy for Inflammatory Bowel Disease: Real-World Comparative Effectiveness and Impact of Drug Sequencing in 13 222 Patients within the UK IBD BioResource.
Kapizioni C. et al, (2024), Journal of Crohn's & colitis, 18, 790 - 800
Identification and validation of a blood- based diagnostic lipidomic signature of pediatric inflammatory bowel disease.
Salihovic S. et al, (2024), Nature communications, 15
Immunogenicity of third dose COVID-19 vaccine strategies in patients who are immunocompromised with suboptimal immunity following two doses (OCTAVE-DUO): an open-label, multicentre, randomised, controlled, phase 3 trial.
Goodyear CS. et al, (2024), The Lancet. Rheumatology, 6, e339 - e351
Antibody, not Cellular, Immune Responses to SARS-CoV-2 Vaccination Outperform Infection in Inflammatory Bowel Disease Patients.
González Cueto E. et al, (2024), Inflammatory bowel diseases, 30, 859 - 862
Challenges in IBD Research 2024: Precision Medicine.
Syed S. et al, (2024), Inflammatory bowel diseases, 30, S39 - S54
Safety and efficacy of autologous haematopoietic stem-cell transplantation with low-dose cyclophosphamide mobilisation and reduced intensity conditioning versus standard of care in refractory Crohn's disease (ASTIClite): an open-label, multicentre, randomised controlled trial.
Lindsay JO. et al, (2024), The lancet. Gastroenterology & hepatology, 9, 333 - 345
Sodium fluoride preserves blood metabolite integrity for biomarker discovery in large-scale, multi-site metabolomics investigations
Xiong W. et al, (2024), The Analyst, 149, 1238 - 1249
Dietary Inflammatory Indices Are Not Associated With Inflammatory Bowel Disease Incidence and Progression.
Wellens J. et al, (2023), Inflammatory bowel diseases
Current and emerging biomarkers for ulcerative colitis.
Nowak JK. et al, (2023), Expert review of molecular diagnostics, 23, 1107 - 1119
SARS-CoV-2-specific immune responses and clinical outcomes after COVID-19 vaccination in patients with immune-suppressive disease
Barnes E. et al, (2023), Nature Medicine, 29, 1760 - 1774
Editorial: in search of environmental risk factors of Crohn's disease and ulcerative colitis with mendelian randomisation-authors' reply.
Chen J. et al, (2023), Alimentary pharmacology & therapeutics, 57, 1034 - 1035